Invasive meningococcal disease (IMD) is a serious public health threat, characterized by rapid symptom onset and high fatality rate, even after treatment. Efforts to prevent IMD remain challenging, because there is neither an immunogenic vaccine for infants nor a vaccine to prevent serogroup B disease that is currently licensed. This article, published in Clinical Infectious Diseases, summarizes current US recommendations for vaccine prevention of meningococcal disease and strategies to improve vaccine coverage among adolescents.

Author(s): Poland GA

Published: 2010

Resource types: Peer-reviewed journal

Diseases: Meningococcus

Topics: Disease/vaccine specific information

Regions: North America and Europe